Found 3 hits for monomerid = 347488 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Histone deacetylase 1
(Homo sapiens (Human)) | BDBM347488
![PNG](/data/jpeg/tenK34/BindingDB_347488.png) (US9790180, ID 021)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C29H34N4O2S/c30-25-13-10-22(27-7-4-18-36-27)19-26(25)32-28(34)20-8-11-23(12-9-20)31-24-14-16-33(17-15-24)29(35)21-5-2-1-3-6-21/h4,7-13,18-19,21,24,31H,1-3,5-6,14-17,30H2,(H,32,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| Assay Description Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were... |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this Ligand-Target Pair | |
Histone deacetylase 3
(Homo sapiens (Human)) | BDBM347488
![PNG](/data/jpeg/tenK34/BindingDB_347488.png) (US9790180, ID 021)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C29H34N4O2S/c30-25-13-10-22(27-7-4-18-36-27)19-26(25)32-28(34)20-8-11-23(12-9-20)31-24-14-16-33(17-15-24)29(35)21-5-2-1-3-6-21/h4,7-13,18-19,21,24,31H,1-3,5-6,14-17,30H2,(H,32,34) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 555 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this Ligand-Target Pair | |
Histone deacetylase 2
(Homo sapiens (Human)) | BDBM347488
![PNG](/data/jpeg/tenK34/BindingDB_347488.png) (US9790180, ID 021)Show SMILES Nc1ccc(cc1NC(=O)c1ccc(NC2CCN(CC2)C(=O)C2CCCCC2)cc1)-c1cccs1 Show InChI InChI=1S/C29H34N4O2S/c30-25-13-10-22(27-7-4-18-36-27)19-26(25)32-28(34)20-8-11-23(12-9-20)31-24-14-16-33(17-15-24)29(35)21-5-2-1-3-6-21/h4,7-13,18-19,21,24,31H,1-3,5-6,14-17,30H2,(H,32,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![](/images/AffyNet_logo.png)
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 72 | n/a | n/a | n/a | n/a | n/a | n/a |
REGENACY PHARMACEUTICALS, LLC
US Patent
| |
US Patent US9790180 (2017)
BindingDB Entry DOI: 10.7270/Q2GF0WM8 |
More data for this Ligand-Target Pair | |